Date Title Description PDF
26 Jul 2023 On buy-back programmes The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.   Download
26 Jul 2023 On P&L The Company releases the press release related to the first half 2023 financial results Download
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download

Pages

Date Title Description PDF
02 Oct 2025 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the third quarter of 2025 Download
04 Jul 2025 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2025 Download
03 Jul 2025 Other relevant information The Company informs about the dividends payment.  Download
18 Jun 2025 Announcement of general shareholders’ meeting The Company reports on the resolutions adopted by the Ordinary General Shareholders' Meeting and by the Board of Directors. Download
08 May 2025 Announcement of General Shareholders’ Meeting The Company announces the call of its 2025 Ordinary General Shareholders' Meeting Download

Pages

Date Title Description PDF
24 Feb 2016 Informe anual de remuneraciones de los consejeros 2015 ROVI releases the 2015 annual report regarding remuneration of the members of the Board of Directors Download
23 Dec 2015 Otros sobre operaciones corporativas Download
21 Dec 2015 Otros sobre operaciones corporativas Download
01 Dec 2015 Otros sobre gobierno corporativo Download
01 Dec 2015 Otros sobre Gobierno Corporativo (2) Download

Pages